Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

41 / 41
Date Title Description PDF
16 Nov 2021 On business and financial situation The Company releases the presentation related to its strategy update because of its 2021 Capital Markets Day Download
15 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 5 November 2021 and 12 November 2021 Download
05 Nov 2021 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 3 and 4 November Download
03 Nov 2021 On business and financial situation The Company releases the press release related to the first nine months 2021 financial results Download
03 Nov 2021 On business and financial situation The Company releases the first nine months 2021 financial results presentation Download

Pages

110 / 150
Date Title Description PDF
05 Oct 2017 Contratos de liquidez y contrapartida Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017. Download
03 Oct 2017 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted from 11 July to 30 September 2017   Download
07 Sep 2017 Otros sobre negocio y situación financiera The Company informs that commences the enoxaparin biosimilar marketing in Germany Download
26 Jul 2017 Información sobre resultados ROVI releases the presentation related to the 2017 first half results Download
26 Jul 2017 Información sobre resultados ROVI releases the presentation related to the 2017 first half results Download

Pages

70 / 194